Depending on the model chosen, Horus Pharma supports all or part of development and profit sharing with the scientist, the University or the company behind the innovative idea.
Laboratory experts rely on their market experience to make strategic choices, generating added value.
Beyond scientific expertise and marketing, Horus Pharma can help expand product distribution through partners and an efficient sales network. Distribution agreements are underway for the EEC, Africa and Asia. The network kicked off with its first subsidiary in Switzerland.
The development and filing of patents solidifies the potential for innovation and multidisciplinarity in the Research and Development teams. A common theme guides this ambitious research policy: the development of solutions allows us to avoid use of any preservatives, while guaranteeing maximum efficiency and microbiological quality.
Developed in partnership with CEMEF and labelled by the Artemis regional innovation centre, the Ifree System® is a multi-dose vial for preservative-free eye drops and ophthalmic gels. Its design incorporates the ergonomic constraints necessary for easy use, particularly by the elderly.
Made using a unique manufacturing process, Epifree® Technology is based on a low temperature sterilisation system that preserves the quality of assets, without the use of preservatives. Highly concentrated in active ingredients, dermatological products from the Ilast® range benefit from the Epifree® Technology patent from the HORUS PHARMA R&D laboratory. Ilast® thus establishes itself as the first patented range of medical devices with preservative, fragrance and alcohol free eyelid care and hygiene.